Sun Pharma Q2 PAT rises 10.5% YoY to Rs 2,262 crore on robust sales

Gross sales came in at Rs 10,809.2 crore, growing by 13.1% over Q2 last year

Mumbai-headquartered Sun Pharmaceutical Industries has posted a 10.5 per cent year-on-year (YoY) rise in net profit for the second quarter of the current fiscal, riding on a 13.1 per cent rise in gross revenues.

Gross sales came in at Rs 10,809.2 crore, growing by 13.1 per cent over Q2 last year, while the net profit for the quarter was at Rs 2262.2 crore, up by 10.5 per cent YoY, impacted by lower other income.

Sun Pharma shares were up 1.68 per cent on the BSE at 3:00 p.m. in the afternoon, at Rs 1,033 each.

US formulation sales came in